A double-blind randomized comparative clinical trial to evaluate the safety and efficacy of dendritic cell vaccine loaded with WT1 peptides (TLP0-001) in combination with S-1 in patients with advanced pancreatic cancer refractory to standard chemotherapy.
Masahiro KatsudaMotoki MiyazawaToshiyasu OjimaAkio KatanumaKenichi HakamadaKentaro SudoShingo AsaharaItaru EndoMakoto UenoKazuo HaraSuguru YamadaTsutomu FujiiSohei SatoiTatsuya IokaMasaichi OhiraTakahiro AkahoriMasayuki KitanoHiroaki NaganoMasayuki FurukawaTomohiko AdachiHiroki YamauePublished in: Trials (2019)
University Hospital Medical Information Network Clinical Trials Registry, UMIN000027179 . Registered on 9 April 2017.
Keyphrases
- clinical trial
- dendritic cells
- double blind
- phase ii
- open label
- phase iii
- placebo controlled
- drug delivery
- regulatory t cells
- healthcare
- locally advanced
- immune response
- study protocol
- cancer therapy
- health information
- wound healing
- amino acid
- randomized controlled trial
- rectal cancer
- squamous cell carcinoma
- radiation therapy
- social media
- network analysis